NBTX Stock Analysis: Buy, Sell, or Hold?
NBTX - Nanobiotix S.A. American Depositary Shares
$51.50
-3.57 (-6.48%)
▼
5d:
+13.21%
30d:
+58.66%
90d:
+103.24%
SELL
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 28, 2026
0d
Get Alerted When NBTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⚠️ CAUTION: NBTX is extended with warning signals. Market expects 41.2% growth which appears unrealistic based on history. Consider taking profits.
⚠️ CAUTION: NBTX is extended with warning signals. Market expects 41.2% growth which appears unrealistic based on history. Consider taking profits.
In-depth Analysis How we analyze
Valuation Analysis: NBTX is currently trading at $51.50, which is considered extended relative to its 30-day fair value range of $29.60 to $45.34. From a valuation perspective, the stock is trading at a premium (Forward PE: 411.7) compared to its historical average (146.3). At these levels, the market is pricing in 41.2% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, NBTX is in a strong uptrend. Immediate support is located at $30.30, while resistance sits at $57.14. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: NBTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $33.75. Given the valuation headwinds and technical position, caution is warranted at these levels.
Technical Outlook: Technically, NBTX is in a strong uptrend. Immediate support is located at $30.30, while resistance sits at $57.14. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: NBTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $33.75. Given the valuation headwinds and technical position, caution is warranted at these levels.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.60 -
$45.34
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
33.3%
All Signals
- BEARISH: Price significantly overextended (+13.6% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.5%)
- BEARISH: Trading 34.5% above Wall St target ($33.75)
- BEARISH: Market expects 41.2% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$29.60 -
$45.34
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$30.30
Resistance Level
$57.14
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
411.67
Wall Street Target
$33.75
(-34.5%)
Revenue Growth (YoY)
186.8%
Profit Margin
-73.5%
Valuation Premium vs History
+41.2% premium
PE vs Historical
411.7 vs 146.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+41.2%
(market-implied from PE analysis)
1-Year Target
$72.72
(+41%)
2-Year Target
$102.68
(+99%)
3-Year Target
$144.98
(+182%)
3-Yr Target (if PE normalizes)
(PE: 412→146)
PE COMPRESSION
$51.52
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 411.7, Growth: 72.6%)
$173.81
(+238%)
Base:
(SPY PE: 22.1, Growth: 72.6%)
$9.32
(-82%)
Bear:
(PE: 18.8, Growth: 72.6%)
$7.92
(-85%)
Share & Embed Analysis
Last updated: May 18, 2026 8:30 AM ET
Data refreshes hourly during market hours. Next update: 9:30 AM
Data refreshes hourly during market hours. Next update: 9:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
